EUCTR2006-001641-33-DE进行中（未招募）1 期
Positronen-Emissionstomographie-gesteuerte Therapie aggressiver Non-Hodgkin-Lymphome (Positron emission tomography guided therapy of aggressive non-Hodgkin's lymphomas) - PETAL-Studie (PETAL trial)
niversitätsklinikum Essen0 个研究点目标入组 696 人开始时间: 2007年4月25日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 696
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Diagnosis of aggressive non-Hodgkin's lymphoma
- •B cell type
- •diffuse large B cell lymphoma including variants and subtypes
- •follicular lymphoma grade 3
- •T cell type
- •anaplastic large T or 0 cell lymphoma
- •angioimmunoblastic T cell lymphoma
- •peripheral T cell lymphoma not otherwise specified
- •intestinal T/NK cell lymphoma
- •hepatosplenic gamma-delta T cell lymphoma
- •subcutaneous panniculitis-like T cell lymphoma
- •Pathological PET scan before treatment
- •Performance status ECOG 0 - 3
- •Age 18 - 80 years
- •Effective contraception
- •Availability of patient for treatment and follow-up
- •Ability to understand the purpose of the trial and act accordingly
- •Compliance of patient
- •Signed informed consent
- •Lack of exclusion criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 400
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 250
排除标准
- •Burkitt's lymphoma
- •Primary cerebral lymphoma
- •Start of therapy before attempted inclusion (except pre-phase therapy of the study protocol)
- •Prior chemo- and/or radiotherapy
- •Other neoplastic diseases within the preceding 5 years (except carcinoma in situ or basal cell carcinoma of the skin)
- •Active viral hepatitis, HIV infection or other uncontrolled infections
- •Severe organ dysfunction not explained by the lymphoma precluding administration of chemotherapy according to the study protocol
研究者
相似试验
已完成
不适用
Positron emission tomography (PET) guided therapy of diffuse large B-cell non-Hodgkin's lymphoma (DLBCL) with or without high dose chemotherapy followed by autologous stem cell transplantation (HDC/ASCT)Diffuse large B-cell lymphomaJPRN-UMIN000004420Japan Study Group for Cell Therapy and Transplantation68
已完成
不适用
Positron Emission Tomography And Recovery following Revascularization: Outcomes and Cost-Effectiveness using F-18-fluorodeoxyglucose (FDG) PET in Severe Left Ventricular Dysfunction (PARR Phase 2)Coronary artery disease, LV dysfunction, congestive heart failureCirculatory SystemCoronary artery diseaseISRCTN00827330niversity of Ottawa Heart Institute (Canada)430
招募中
不适用
Positron emission tomography with innovative laboratory techniques for improved risk and disease assessment in myelomaMyelomatosis10018865NL-OMON53692niversiteit Antwerpen40
已完成
不适用
Brain imaging of the adenosine A2A receptor in schizophreniaSchizophreniaISRCTN05808181King's College London (UK)18
尚未招募
不适用
Positron Emission Tomography as a diagnostic tool in Unilateral Condylar Hyperplasia and comparison with bone scintigraphy, including SPECTTemporo-Mandibulaire Gewrichtgrowth of the temporo-mandibular jointUnilateral Condylar HyperplasiaNL-OMON30174Vrije Universiteit Medisch Centrum6